Who owns IMMUNOPHARMA AS?

BOHAN & CO AS is the largest registered owner, with 35.4%.

What is the revenue of IMMUNOPHARMA AS?

IMMUNOPHARMA AS had revenue of NOK 12.2m in 2024.

Who is the general manager of IMMUNOPHARMA AS?

Knut Christian Espeseth is registered as general manager of IMMUNOPHARMA AS.

Where is IMMUNOPHARMA AS based?

IMMUNOPHARMA AS has its business address in Oslo.

Activities of advertising agencies

IMMUNOPHARMA AS

Org. no. 994924273 Limited company (AS) Oslo Incorporated 2009 Active

Ownership graph ↗

Revenue 2024 NOK 12.2m

Operating profit NOK −38.5m

Equity NOK 209.0m

Incorporated 2009

Employees 13

Share capital NOK 13.9m

Overview Details Financials Key figures Roles and owners Organisation Announcements IP rights

Announcements

Changes recorded in the Brønnøysund registers, collected continuously from the update feed.

15 Jul 2026 Register change

Enhet endret i Enhetsregisteret
1 Jul 2026 Register change

Enhet endret i Enhetsregisteret
13 Jun 2026 Register change

Enhet endret i Enhetsregisteret
12 May 2026 Register change

Enhet endret i Enhetsregisteret
14 Apr 2026 Register change

Enhet endret i Enhetsregisteret
13 Dec 2025 Register change

Enhet endret i Enhetsregisteret
13 Sep 2025 Register change

Enhet endret i Enhetsregisteret
25 Aug 2025 Register change

Enhet endret i Enhetsregisteret
14 May 2025 Register change

Enhet endret i Enhetsregisteret
12 Feb 2025 Register change

Enhet endret i Enhetsregisteret
14 Jan 2025 Register change

Enhet endret i Enhetsregisteret
18 Jul 2024 Register change

Enhet endret i Enhetsregisteret
12 Jun 2024 Register change

Enhet endret i Enhetsregisteret
4 Jun 2024 Register change

Enhet endret i Enhetsregisteret
13 Jan 2024 Register change

Enhet endret i Enhetsregisteret
12 Dec 2023 Register change

Enhet endret i Enhetsregisteret
12 Oct 2023 Register change

Enhet endret i Enhetsregisteret
12 Sep 2023 Register change

Enhet endret i Enhetsregisteret
17 Aug 2023 Register change

Enhet endret i Enhetsregisteret
14 Dec 2022 Register change

Enhet endret i Enhetsregisteret
12 Nov 2022 Register change

Enhet endret i Enhetsregisteret
16 Aug 2022 Register change

Enhet endret i Enhetsregisteret
9 Jul 2022 Register change

Enhet endret i Enhetsregisteret
13 Dec 2021 Register change

Enhet endret i Enhetsregisteret
15 Nov 2021 Register change

Enhet endret i Enhetsregisteret
1 Nov 2021 Register change

Enhet endret i Enhetsregisteret
18 Oct 2021 Register change

Enhet endret i Enhetsregisteret
14 Oct 2021 Register change

Enhet endret i Enhetsregisteret
12 Oct 2021 Register change

Enhet endret i Enhetsregisteret
22 Sep 2021 Register change

Enhet endret i Enhetsregisteret
16 Sep 2021 Register change

Enhet endret i Enhetsregisteret
13 Mar 2021 Register change

Enhet endret i Enhetsregisteret
16 Feb 2021 Register change

Enhet endret i Enhetsregisteret
12 Sep 2020 Register change

Enhet endret i Enhetsregisteret
4 Feb 2020 Register change

Enhet endret i Enhetsregisteret
1 Jan 2020 Register change

Enhet endret i Enhetsregisteret
31 Dec 2019 Register change

Enhet endret i Enhetsregisteret
6 Jul 2019 Register change

Enhet endret i Enhetsregisteret

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Free · complete

Get the full picture ofIMMUNOPHARMA AS

Open the full company report for complete insight.

Detailed financials and key figures

Valuation and financial analysis

Roles, owners and group structure

Credit rating and payment history

Comparison and trends over time

IMMUNOPHARMA AS · Rapport

Open the full report →

Secure and simple

Valuation

NOK 176.7m

NOK 124.5m – NOK 313.5m

Confidence: low
Method: asset_only
Norm. EBIT: NOK −38.5m
Required return: 22.0%
Book equity: NOK 209.0m

See the full valuation →

Ownership graph

Explore the full ownership structure and group map interactively.

Open the graph ↗